More than $70,000 among nearly 30 drinks were sold in many downtown establishments. See who won the drinks competition.
Altimmune has shared an update on the metabolic dysfunction-associated steatohepatitis (MASH) study that sank its stock in June. The 48-week readout linked the top dose of the GLP-1/glucagon dual ...
Approximately a third of the adult population worldwide has MASLD, the presence of steatosis (the accumulation of fat) in the ...
Downtown Sioux Falls announced the three winners for Mash Madness 2026!
This article originally appeared on HCPLive®. The FDA has granted breakthrough therapy designation (BTD) for pemvidutide for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). 1 ...
SIOUX FALLS, S.D. (KELO) — Here’s a look at today’s top stories for KELOLAND On the Go. A Piedmont man died Friday evening in a four-vehicle crash one mile east of Deadwood, SD. The driver of the ...
CONSHOHOCKEN, Pa., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic ...